Imunon, Inc. Logo

Imunon, Inc.

A clinical-stage biotech developing immunotherapies and DNA-based vaccines.

IMNN | US

Overview

Corporate Details

ISIN(s):
US15117N6022
LEI:
Country:
United States of America
Address:
997 LENOX DRIVE, 8648 LAWRENCEVILLE

Description

Imunon, Inc. is a clinical-stage biotechnology company that develops novel immunotherapies and DNA-based vaccines. The company's core focus is on creating treatments for challenging conditions, including cancer and infectious diseases, by harnessing the patient's immune system. Its proprietary technology platforms are centered on immunology and nucleic acid-based therapies. The lead candidate in its pipeline is IMNN-001, a DNA-based immunotherapy in clinical development for advanced ovarian cancer. Imunon oversees the complete drug development lifecycle, from initial research and discovery to manufacturing in its in-house GMP-compliant facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-06 18:21
FORM 4
English 7.4 KB
2025-08-05 11:00
10-Q
English 1.0 MB
2025-08-05 10:03
8-K
English 139.5 KB
2025-07-28 10:10
8-K
English 99.1 KB
2025-07-23 10:02
8-K
English 119.0 KB
2025-07-22 10:05
8-K
English 115.2 KB
2025-07-22 10:00
424B5
English 27.8 KB
2025-07-14 19:12
8-K
English 144.5 KB
2025-07-11 19:00
8-K
English 79.7 KB
2025-06-17 18:26
FORM 3
English 7.5 KB
2025-06-16 02:15 English 5.2 KB
2025-06-13 19:15
8-K
English 1.8 MB
2025-06-13 19:10
424B3
English 119.8 KB
2025-06-11 18:20
ARS
English 1.5 MB
2025-06-11 18:10 English 24.7 KB

Automate Your Workflow. Get a real-time feed of all Imunon, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Imunon, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Imunon, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.